CLINICAL_TRIALS
research
· 2009-03-03
Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer [Phase 1]
Summary
A Phase 1 clinical trial update exploring radiolabeled monoclonal antibody therapy for relapsed or refractory non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Garden State Cancer Center at the Center for Molecular Medicine and Immunology | Conditions: Lung Cancer | Phase 1 | Status: UNKNOWN